[{"data": {"name": "Safety and pharmacodynamics of dalazatide, a Kv1.3 channel inhibitor, in the treatment of plaque psoriasis: A randomized phase 1b trial", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Eric J. Tarcha", "@type": "Person"}, {"name": "Chelsea M. Olsen", "@type": "Person"}, {"name": "Peter Probst", "@type": "Person"}, {"name": "David Peckham", "@type": "Person"}, {"name": "Ernesto J. Mu\u00f1oz-El\u00edas", "@type": "Person"}, {"name": "James G. Kruger", "@type": "Person"}, {"name": "Shawn P. Iadonato", "@type": "Person"}], "license": "cc-by", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0180762&type=printable", "encodingFormat": "application/pdf"}, {"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc5516987?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "Public Library of Science (PLoS)", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1371/journal.pone.0180762", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCd74qLgVWNqN-CThNXyJRbLGFe-CDP4TaSaXeWTd-CR8wPB7QCTGo5", "propertyID": "ISCC"}], "datePublished": "2017-07-19"}, "schema": "schema.org", "mediatype": "application/ld+json"}]